Pharmaceutical Research Associates Inc
Pharmaceutical Research Associates Inc. (PRA Health Sciences) is a leading global contract research organisation headquartered in the United States. Founded in 1976, PRA has established a strong presence in key operational regions, including Europe and Asia, providing comprehensive services across the pharmaceutical and biotechnology industries. Specialising in clinical development, PRA offers a range of services from Phase I-IV clinical trials to data management and regulatory consulting. Their commitment to innovation and patient-centric solutions sets them apart in a competitive market. With a robust portfolio and a reputation for excellence, PRA has achieved significant milestones, including numerous successful drug approvals and partnerships with major pharmaceutical companies. This positions PRA as a trusted partner in advancing healthcare and improving patient outcomes worldwide.
DitchCarbon Score
How does Pharmaceutical Research Associates Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Heavy Fuel Oil industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaceutical Research Associates Inc's score of 3 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Research Associates Inc's reported carbon emissions
In 2019, Pharmaceutical Research Associates Inc reported total carbon emissions of approximately 31,296,000 kg CO2e. This figure includes 485,000 kg CO2e from Scope 1 emissions, primarily from stationary combustion, and 8,456,000 kg CO2e from Scope 2 emissions related to purchased electricity. The majority of their emissions, about 22,355,000 kg CO2e, fall under Scope 3, attributed to business travel. Over the years, the company has seen fluctuations in its emissions, with a peak of approximately 32,428,000 kg CO2e in 2016. Despite these figures, there are currently no publicly disclosed reduction targets or initiatives aimed at decreasing their carbon footprint. This lack of specific climate commitments may reflect broader industry challenges in addressing emissions, particularly in the pharmaceutical sector, where business travel and energy consumption are significant contributors to overall carbon output. Pharmaceutical Research Associates Inc's emissions data highlights the need for enhanced climate strategies to mitigate their environmental impact effectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|---|
| Scope 1 | 778,650 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 4,234,160 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmaceutical Research Associates Inc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
